Maëva Z.
- Country
- France
- Department
- Pneumology
Research Overview
- Phase 2b/3 Randomized Double‑Blind Placebo‑Controlled Trial of Lunsekimig in Adults with Inadequately Controlled Eosinophilic COPD
- Evaluation of Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Patients
- Phase 2 Evaluation of Fianlimab, Cemiplimab, and Chemotherapy Versus Cemiplimab and Chemotherapy in Resectable Stage II-IIIB (N2) Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 82 of 486 partner sites.
Specializations
Respiratory Medicine
Specializes in investigating innovative treatments for Chronic Obstructive Pulmonary Disease (COPD), with particular emphasis on exacerbation management and airway disease control.
- Airway Disease Management
- Mucus Rheology Assessment
- COPD Exacerbation Prevention
Investigates the relationship between mucus characteristics and disease progression in chronic airway conditions.
Hepatology
Conducts research in the treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease, focusing on novel therapeutic approaches to address liver fibrosis.
- Liver Fibrosis Treatment
- Genetic Liver Disorders
- Protein Deficiency Conditions
Explores innovative therapeutic interventions for rare genetic liver conditions and their complications.
Therapeutic Innovation
Focuses on evaluating combination therapies for respiratory conditions, particularly investigating the impact of multiple-agent treatments on cardiopulmonary outcomes.
- Inhaled Combination Therapies
- Cardiopulmonary Outcomes
- Bronchodilator Research
Studies the comparative effectiveness of dual and triple therapy combinations in respiratory medicine.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.